{
  "claims": [
    {
      "claim_id": "C01",
      "claim": "Intratumoral mRNA vaccination sensitizes tumors to immune checkpoint blockade by broadening antigen presentation.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "The paper investigates whether intratumoral delivery of an mRNA vaccine can create an interferon-rich inflammatory state that improves sensitivity to anti-PD-L1 therapy.",
          "line_ref": "L11"
        },
        {
          "quote": "Broader antigen display after intratumoral mRNA vaccination",
          "line_ref": "L28"
        }
      ],
      "caveat": "The human analysis is retrospective and non-randomized; residual confounding is likely."
    },
    {
      "claim_id": "C02",
      "claim": "SARS-CoV-2 mRNA vaccination is associated with improved survival in patients receiving immune checkpoint inhibitors.",
      "strength": "moderate",
      "evidence": [
        {
          "quote": "Retrospective human survival comparison p-value",
          "line_ref": "L30"
        },
        {
          "quote": "Vaccinated subgroup had improved survival under ICI treatment",
          "line_ref": "L30"
        }
      ],
      "caveat": "Tumor-type mix and treatment-history heterogeneity limit direct causal interpretation."
    },
    {
      "claim_id": "C03",
      "claim": "The sensitization effect of mRNA vaccines is dependent on Type I interferon signaling.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "Type I interferon response score (normalized units)",
          "line_ref": "L31"
        },
        {
          "quote": "Blocking type I interferon signaling with anti-IFNAR1 eliminated the observed sensitization benefit.",
          "line_ref": "L39"
        }
      ],
      "caveat": "Some mechanistic readouts were strongest in specific model systems rather than uniformly across all tested settings."
    },
    {
      "claim_id": "C04",
      "claim": "Intratumoral mRNA vaccination increases PD-L1 expression, making the tumor more targetable by ICIs.",
      "strength": "strong",
      "evidence": [
        {
          "quote": "PD-L1 expression fold-change in tumor tissue",
          "line_ref": "L32"
        },
        {
          "quote": "Checkpoint axis became more targetable",
          "line_ref": "L32"
        }
      ],
      "caveat": "Mouse model effects may not map one-to-one to all human tumors."
    }
  ]
}
